Defective Breast Mesh, Acellular Dermal Matrix (ADM), and Bioabsorbable Scaffold Injury Attorneys in West Virginia: The Complete Guide for Women, Families, and Survivors
For women in West Virginia who have undergone breast reconstruction after a mastectomy, prophylactic surgery due to BRCA1/BRCA2 mutations, or cosmetic breast procedures, the path to healing is often fraught with physical and emotional challenges. In many of those surgeries — whether performed at major academic centers like the West Virginia University (WVU) Heart and Vascular Institute’s surgical wings or regional hubs like Charleston Area Medical Center (CAMC) — medical devices such as acellular dermal matrix (ADM), bioabsorbable scaffolds, and synthetic meshes were implanted. We know that for many West Virginia survivors, the expectation was that these products would provide the “internal bra” support needed for a successful result.
When these devices fail, the consequences are catastrophic. We are currently seeing a rise in reports of deep surgical site infections, reconstruction failure, and late-onset malignancies like Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) and Breast Implant-Associated Squamous Cell Carcinoma (BIA-SCC). At Attorney911, led by Managing Partner Ralph Manginello — who has been licensed for 27 years (Bar Card 24007597) and is admitted to the United States District Court for the Southern District of Texas — we provide the technical and doctrinal command required to hold manufacturers accountable.
If you were told your implants or scaffolds were safe, but you are now facing revision surgery or a life-altering diagnosis in West Virginia, our team is here to help. Our Associate Attorney, Lupe Peña, brings a unique advantage with her background in insurance defense and her ability to conduct full consultations in fluent Spanish (Hablamos español), ensuring that no West Virginia family is barred from justice because of a language gap. You can reach us at 1-888-ATTY-911 for a confidential, no-obligation consultation.
Understanding the Devices: ADM, Scaffolds, and Mesh in West Virginia Breast Surgery
In the medical communities of West Virginia, from Morgantown to Huntington and Parkersburg, plastic and reconstructive surgeons have increasingly utilized three categories of products to assist in breast surgery. These are often used “off-label,” meaning the FDA never cleared them specifically for use in breast tissue.
Acellular Dermal Matrix (ADM)
ADM is a biologic material derived from human cadavers or animal tissue (porcine or bovine). The cells are removed, leaving a collagen scaffold designed to be integrated into the patient’s own tissue. Brands commonly found in West Virginia operating rooms include:
- AlloDerm and AlloDerm RTU (Allergan/AbbVie/LifeCell)
- Strattice (Allergan/AbbVie)
- FlexHD and FlexHD Pliable (MTF Biologics)
- AlloMax (C.R. Bard/Becton Dickinson)
- SurgiMend (Integra LifeSciences)
Bioabsorbable and Resorbable Scaffolds
These are synthetic materials designed to provide temporary support before being absorbed by the body. The most controversial is poly-4-hydroxybutyrate (P4HB).
- GalaFLEX Scaffold (Galatea Surgical/BD)
- Phasix Mesh (C.R. Bard/BD)
- DuraSorb (Surgical Innovation Associates)
- TIGR Matrix (Novus Scientific)
Synthetic Surgical Mesh
While traditionally used for hernia repair, some West Virginia surgeons have used permanent polypropylene mesh in the breast. These products were never designed for the delicate environment of breast tissue and carry significant risks of erosion and chronic inflammation.
Ralph Manginello and our team emphasize that under 21 CFR Part 803, manufacturers have a strict duty to report adverse events. When products like GalaFLEX or FlexHD cause injury, the manufacturer cannot hide behind a surgeon’s decision to use them.
The FDA Regulatory Failure: Why West Virginia Patients Were Never Warned
The most shocking fact for many of our clients in West Virginia is that the FDA has never determined the safety and effectiveness of surgical mesh for breast surgery. As specified in the FDA’s November 9, 2023, letter to health care providers: “The safety and effectiveness of surgical mesh in breast surgery, including in augmentation or reconstruction, has not been determined by the FDA.”
Most of these devices entered the market through the 510(k) clearance pathway (21 USC §360c and 21 CFR Part 807 Subpart E). This is not a “PMA” (Premarket Approval) process. Instead, it is a shortcut where a manufacturer claims their product is “substantially equivalent” to a predicate device. For example, GalaFLEX cited a surgical suture as its predicate. This “predicate creep” allowed devices to be implanted in West Virginia women without any breast-specific clinical trials.
The legal implications of this are governed by the Supreme Court’s decision in Medtronic v. Lohr, 518 U.S. 470 (1996), which establishes that 510(k) clearance does not preempt state-law claims. Unlike PMA-approved devices that might be shielded under Riegel v. Medtronic, 552 U.S. 312 (2008), 510(k) devices are fully subject to product liability lawsuits for design defects, manufacturing defects, and failure to warn.
The Complication Spectrum: From Chronic Pain to BIA-ALCL
If you are a patient in West Virginia who has felt a “hardness” in the breast, experienced sudden swelling, or noticed the edges of a mesh product poking through your skin (extrusion), you are not alone. Our firm leverages medical records and pathology to prove device failure.
BIA-ALCL and BIA-SCC Pathology
We focus heavily on oncological complications specifically linked to textured surfaces and implant capsules.
- BIA-ALCL: This is a distinct T-cell lymphoma, not breast cancer. Pathologically, it is CD30 positive and ALK negative. West Virginia patients with Allergan BIOCELL textured implants (recalled in July 2019) should be screened for periprosthetic seroma or masses occurring years after surgery.
- BIA-SCC: Squamous cell carcinoma of the breast implant capsule. The FDA issued a safety communication in September 2022 and an update on March 8, 2023, identifying this as a serious risk for both textured and smooth implants.
Red Breast Syndrome (RBS)
Often mistaken for an infection in West Virginia clinics, RBS is a sterile inflammatory response to acellular dermal matrix. Research (Nguyen et al., 2019) points to endotoxin contamination on the ADM scaffold as the primary cause. While the device may be “sterile” under 21 CFR standards, the lipopolysaccharides (LPS) from dead bacteria trigger a massive immune response.
Surgical Site Complications
- Skin-flap necrosis: Tissue death overlying the reconstruction site.
- Capsular contracture: Baker Grade III/IV hardening that can distort the breast and cause severe pain.
- Chronic seroma: Persistent fluid collection that requires repeated drainage.
If you are suffering from any of these, we invite you to call 1-888-ATTY-911. We provide the technical authority that generalist personal injury firms lack. Our success in high-profile litigation, such as the Bermudez v. Pi Kappa Phi case (Harris County, 2025), demonstrates our ability to take on large institutional and corporate defendants.
The Dr. Hooman Noorchashm Whistleblower Disclosures
Patients in West Virginia deserve to know the truth about the manufacturers of their medical devices. Dr. Hooman Noorchashm, a former Medical Director at Becton Dickinson (BD), was reportedly terminated in 2022 after raising safety alarms about GalaFLEX and Phasix mesh.
His whistleblower record reveals allegations that:
- Breast cancer recurrences in BD’s GalaFLEX trials were withheld from the FDA.
- Significant adverse events in the MAUDE (Manufacturer and User Facility Device Experience) database were manipulated or under-reported.
- Manufacturers targeted West Virginia surgeons with off-label marketing for “internal bra” procedures despite knowing the safety risks.
Ralph Manginello and Lupe Peña use this investigative authority to pierce the corporate “learned intermediary” defense, arguing that manufacturers compromised the independent judgment of West Virginia doctors through aggressive, misleading promotion.
Product Liability and Legal Rights in West Virginia
Under West Virginia’s product liability framework, we pursue justice through several doctrinal channels:
Failure to Warn
Manufacturers had a duty to inform West Virginia healthcare providers that these devices were not cleared for breast surgery. Under Perez v. Wyeth Laboratories, 734 A.2d 1245 (1999), when manufacturers market directly to consumers or engage in pervasive off-label promotion, the “learned intermediary” defense fails.
Strict Liability
We argue that products like GalaFLEX and AlloMax were “unreasonably dangerous” as designed for use in the breast. We analyze the Risk-Utility Test and the Consumer Expectation Test as they apply to West Virginia state law.
Parallel Claims and Preemption
Following Buckman Co. v. Plaintiffs’ Legal Committee, 531 U.S. 341 (2001), we avoid “fraud-on-the-FDA” claims that are impliedly preempted. Instead, we bring parallel claims — state law duties that are identical to federal requirements under 21 CFR Part 803 and 21 CFR Part 807. This allows our West Virginia clients to seek compensation for medical bills, lost wages, and permanent disfigurement.
Why West Virginia Patients Trust Attorney911
We are not a “settlement mill.” We are trial lawyers. Our reputation is built on high-stakes advocacy and verified credentials.
- 27 Years of Practice: Ralph Manginello was licensed in November 1998 (Bar Card 24007597) and maintains an Avvo “Excellent” 8.2 rating.
- Bilingual Representation: Lupe Peña (Bar Card 24084332) ensures our Spanish-dominant West Virginia families communicate directly with their attorney without an interpreter.
- Proven Results: We have recovered millions of dollars for clients in catastrophic injury cases, including maritime accidents, oilfield injuries, and complex trucking litigation.
- Current Litigation Capability: Our lead role in the Bermudez v. Pi Kappa Phi $10,000,000 lawsuit is proof of our current readiness to handle multi-defendant litigations against corporate giants like Allergan (AbbVie) and Becton Dickinson.
We hold Martindale-Hubbell Preeminent 5.0 of 5.0 ratings and are recognized members of the Pro Bono College of the State Bar of Texas, proving our commitment to ethics and service.
Frequently Asked Questions for West Virginia Survivors
1. Is there a statute of limitations for a breast mesh case in West Virginia?
Yes. In West Virginia, the statute of limitations for personal injury is generally two years from the date you knew or should have known your injury was caused by the defective product (the “Discovery Rule”). Given the complex nature of mesh degradation and cancer latency, contact us at 1-888-288-9911 immediately to preserve your rights.
2. Is GalaFLEX approved for breast reconstruction?
No. The FDA’s 2023 letter explicitly states it has not been determined safe or effective for breast surgery. It was cleared for hernia and soft-tissue reinforcement, but its use in the breast is considered “off-label.”
3. What is the status of the Allergan BIOCELL MDL 2921?
This consolidated litigation is ongoing in the District of New Jersey before Judge Brian R. Martinotti. For West Virginia women diagnosed with BIA-ALCL after receiving BIOCELL implants, a bellwether trial is currently scheduled for October 19, 2026.
4. Can I sue if the mesh was removed years ago?
Yes, provided you are within the statute of limitations. The preservation of the explanted device, operative reports, and pathology slides from your West Virginia hospital (like St. Mary’s in Huntington) is critical.
5. How much does a consultation cost?
Nothing. At Attorney911, we operate on a contingency fee basis. No recovery, no fee.
Immediate Steps for West Virginia Residents
If you suspect your breast reconstruction is failing or you have received a BIA-ALCL diagnosis, take the following steps:
- Request your Operative Reports: Identify the specific brand and lot number of any ADM or scaffold used.
- Request your “Implant Stickers”: These are unique device identifiers (UDI) provided by manufacturers.
- Preserve the Evidence: If you undergo revision surgery in West Virginia, ensure your surgeon does not return the explanted mesh to the manufacturer. It is your evidence.
- Contact Attorney911: Call 1-888-ATTY-911.
We serve every corner of West Virginia, from the panhandles to the coalfields. Whether you received care at WVU Medicine in Morgantown, Plateau Medical Center in Oak Hill, or any ambulatory surgical center in the state, we are ready to assist you.
Lupe Peña and Ralph Manginello are committed to your recovery. Lupe Peña realiza consultas completas en español para asegurar que la comunidad hispana en West Virginia tenga acceso total a la justicia.
Call 1-888-ATTY-911 or visit our contact page today. Your health, your dignity, and your compensation are our priority. We are the voice for West Virginia’s survivors of defective medical devices.
Professional Verification and E-E-A-T Anchors
The Manginello Law Firm, PLLC, is a member of the Pasadena Chamber of Commerce and maintains a 4.9-star rating on Birdeye with hundreds of verified client reviews. Ralph Manginello’s peer endorsements on Avvo from attorneys like Mark Ryan Thiessen and Stacey Erin Burke further solidify our standing as a top-tier litigation firm. We host the Attorney911 Podcast (Apple Podcast ID 1773141988) and provide educational content on our YouTube channel (@Manginellolawfirm).
Justice for West Virginia women begins with a single phone call. Contact us now. 1-188-ATTY-911.
